Fortis Advisors, LLC Amgen Inc Transaction History

Fortis Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $11.3 Million - $13.2 Million	53,162 New	53,162 $53,000
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $352,893 - $433,048	-1,784 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $3,644 - $4,834	20 Added 1.13%	1,784 $362,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $2,081 - $2,675	11 Added 0.63%	1,764 $425,000
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $2,263 - $2,712	13 Added 0.75%	1,753 $339,000
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $2,167 - $2,540	13 Added 0.75%	1,740 $321,000
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $2,532 - $2,854	-14 Reduced 0.8%	1,727 $328,000
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $2,140 - $2,499	12 Added 0.69%	1,741 $339,000
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $2,223 - $2,506	12 Added 0.7%	1,729 $358,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $1,992 - $2,238	12 Added 0.7%	1,717 $317,000
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $2,033 - $2,376	12 Added 0.71%	1,705 $291,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $1,856 - $2,074	11 Added 0.65%	1,693 $294,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $281,381 - $321,262	1,682	1,682 $314,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortis Advisors, LLC with notifications on news.